Ipr In Valuation Of Digital Health Patents.
1. Introduction to IPR in Digital Health
Digital health refers to the convergence of digital technologies and healthcare, including telemedicine, wearable devices, AI in diagnostics, mobile health apps, and electronic health records (EHRs). Intellectual property rights (IPR) play a pivotal role in protecting innovation and assigning value to these technologies.
Why IPR is critical in digital health valuation:
Patents safeguard innovative medical devices, algorithms, and software.
They determine monetary value in mergers, acquisitions, or licensing deals.
They are essential in negotiating funding, partnerships, and commercialization strategies.
Key types of IPR relevant to digital health:
Patents: Protect inventions like AI diagnostic tools, wearable biosensors, or health monitoring apps.
Copyrights: Protect software code for health applications.
Trademarks: Protect brand names of health apps or devices.
Trade secrets: Protect proprietary algorithms or patient data analytics methods.
Valuation of digital health patents involves determining the economic worth of the patent. This can be done using several approaches:
Cost-based approach: Development costs of the technology.
Market-based approach: Comparable transactions or licensing deals.
Income-based approach: Projected revenue or savings from the technology.
2. Legal Framework for Digital Health Patents
Patent laws globally protect digital health innovations under utility patents if they are:
Novel
Non-obvious
Industrially applicable
However, software and medical method patents often face scrutiny because some jurisdictions (like India and Europe) have restrictions on patenting abstract algorithms or medical procedures “per se.”
In India, Section 3(k) of the Patents Act excludes computer programs “per se” from patentability, but software with technical effect or medical devices can still be patented.
3. Case Laws on Digital Health and IPR
Here are 5 key cases demonstrating how courts value and enforce digital health patents:
Case 1: Mayo Collaborative Services v. Prometheus Laboratories (2012, US)
Court: Supreme Court of the United States
Facts:
Prometheus patented a method of optimizing drug dosage by monitoring metabolite levels in patients. Mayo challenged it, arguing it was a natural law.
Ruling:
The Supreme Court held that laws of nature, natural phenomena, and abstract ideas are not patentable.
Only applications that include additional inventive steps can be patented.
Relevance to digital health:
Digital health algorithms that analyze patient data must demonstrate inventive technical contribution rather than mere data correlation.
Impacts valuation because patents rejected under this doctrine have no market value.
Case 2: Alice Corp. v. CLS Bank International (2014, US)
Court: Supreme Court of the United States
Facts:
Alice Corp owned patents for computer-implemented schemes for mitigating settlement risk in financial transactions. CLS argued the patents were abstract ideas.
Ruling:
Software patents claiming abstract ideas implemented on a computer are not patentable.
A digital health analogy: simply automating a healthcare process with software is insufficient; it must improve technology or medical outcomes.
Impact on valuation:
Patents without clear technical innovation may have negligible licensing or sale value.
This case is frequently cited when evaluating AI/ML algorithms in diagnostics.
Case 3: Enfish, LLC v. Microsoft Corp. (2016, US)
Court: US Court of Appeals for the Federal Circuit
Facts:
Enfish claimed a patent on a self-referential database used to improve data storage and retrieval efficiency. Microsoft challenged it as abstract.
Ruling:
The court ruled the patent was directed at an improvement in computer functionality, not an abstract idea.
Patents that improve computer performance or medical device functionality can be valuable and enforceable.
Relevance to digital health:
Patents for EHR optimization, AI diagnostic systems, or telemedicine platforms can be valued highly if they enhance technical efficiency.
Case 4: Roche v. Cipla (India, 2015)
Court: Delhi High Court, India
Facts:
Roche held patents for pharmaceutical products and diagnostic devices. Cipla challenged them as non-patentable and sought generic entry.
Ruling:
The court examined novelty and inventive step for patent enforcement.
Roche’s diagnostic device patents were upheld, as they involved technical innovation in medical diagnostics.
Implication for valuation:
In India, patents for innovative diagnostic or digital health devices are enforceable, thus increasing valuation for licensing or acquisition.
Case 5: IBM v. Zillow Group (2020, US)
Court: US District Court
Facts:
IBM sued Zillow for infringing patents related to predictive algorithms for decision-making, which can be applied to healthcare risk prediction.
Ruling:
The court validated patents with specific technical improvements in AI-based predictive systems.
Impact on digital health patents:
Algorithms that predict patient health risks, hospital readmissions, or personalized treatment can have strong enforceable patent rights, increasing their valuation.
4. Key Takeaways from Cases
Novelty and technical contribution are critical.
Mere data analysis or medical process automation without inventive improvement is unlikely to be patentable (Mayo, Alice).
Technical implementation matters.
Innovations improving system performance or functionality are patentable and valuable (Enfish, IBM).
Jurisdiction matters.
Indian patent law is stricter on software patents but allows medical devices with technical innovation (Roche v. Cipla).
Valuation depends on enforceability.
Patents at risk of invalidation (abstract ideas) have low licensing or M&A value.
Strong, technical, enforceable patents can command millions in valuation.
5. Methods to Value Digital Health Patents
Based on the cases, valuation can be done using:
Cost-Based Approach
Development cost, R&D expenditure, software/hardware integration.
Useful for early-stage startups.
Market-Based Approach
Comparing licensing deals or acquisitions for similar digital health technologies.
Income-Based Approach
Projected revenue, cost savings, or royalties from patent commercialization.
Example:
An AI diagnostic patent that reduces misdiagnosis by 20% → projected annual revenue of $10M → discounted cash flow can value the patent at $5–7M.
RELATED Blog
comments